Wang and colleagues investigated the effects of LY294002, a PI3K inhibitor, on GC cells, observing that this inhibitor downregulates the expressions of PI3K, AKT, mTOR, S6K, and CYP2E1 [203]. Here, PIK3CB is linked to gastric cancer.